Merck & Co., Inc.
Could not find a ticker for this position, may be a filing error
A maker of prescription medicines and animal health products, Merck produces well-known drugs like the cancer treatment Keytruda and the HPV vaccine Gardasil, along with livestock and pet-care vaccines used by doctors, veterinarians, and farmers. Founded in 1891 as the American branch of a German family firm, the company was seized during World War I and later bought back, becoming an independent U.S. company that today goes by the name MSD outside North America. A fun quirk: its blockbuster Keytruda nearly got shelved — researchers originally set out to calm the immune system, not fight cancer.
Granted 13.3K
Granted 2.5K
Granted 2.6K
Granted 2.0K
Granted 4.7K
Granted 3.9K
Granted 3.0K
Granted 552
Granted 1.4K
Granted 1.4K
Granted 13.4K
Granted 1.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Davis Robert MChairman, CEO & President, Director · 2 transactions | +1.5% | 450.4K | 13.3K | — | — |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth · 2 transactions | -5.2% | 325.7K | 2.5K | — | — |
| Chattopadhyay SanatExe V-P & Pres. MMD · 2 transactions | +0.6% | 258.3K | 2.6K | — | — |
| Guindo ChirfiEVP, Access, Policy & Comms · 2 transactions | -4.8% | 124.3K | 2.0K | — | — |
| Li Dean YExecutive VP & President, MRL · 2 transactions | +2.6% | 94.4K | 4.7K | — | — |
| Litchfield CarolineEVP & CFO · 2 transactions | -30.2% | 92.3K | 3.9K | — | — |
| Zachary JenniferEVP, General Counsel · 2 transactions | +2.9% | 70.9K | 3.0K | — | — |
| Maraldo David R.EVP & Pres. MMD · 2 transactions | — | 44.9K | 552 | — | — |
| Williams David MichaelEVP,Chief Info&Digital Officer · 2 transactions | +2.8% | 31.7K | 1.4K | — | — |
| Oosthuizen Johannes JacobusEVP, Oncology & Int?l · 2 transactions | +3.3% | 21.9K | 1.4K | — | — |
| Larson Betty DEVP, Chief HR Officer · 4 transactions | — | 13.8K | 13.4K | — | — |
| Smart Dalton E. IIISVP Fin. - Global Controller · 6 transactions | -35.7% | 9.4K | 1.8K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.